Along with previous studies which correlated overall increased BCA2 expression with ER-positive status, negative nodal status and increased survival over 5 years [2]; it is more likely that BCA2 is indirectly involved in progression of breast cancer to highly invasive and metastatic disease, rather than a driver of the process. This evidence concerns the gene RNF115 and metastatic neoplasm.